Extended Safety, Immunogenicity and Efficacy of a Blood-Stage Malaria Vaccine in Malian Children: 24-Month Follow-Up of a Randomized, Double-Blinded Phase 2 Trial

MLA

Modibo Daou, et al. “Extended Safety, Immunogenicity and Efficacy of a Blood-Stage Malaria Vaccine in Malian Children: 24-Month Follow-Up of a Randomized, Double-Blinded Phase 2 Trial.” PLoS ONE, vol. 8, no. 11, Nov. 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e46fe5c167ab3122b212142bd910daf5&authtype=sso&custid=ns315887.

APA

Modibo Daou, Joe Cohen, Matthew B. Laurens, Jason W. Bennett, William C. Blackwelder, Abdoulaye K. Kone, Amed Ouattara, Shannon Takala-Harrison, Bourema Kouriba, Amadou Niangaly, Tina J. T. Dube, Ogobara K. Doumbo, Lorraine Soisson, Mahamadou A. Thera, Kirsten E. Lyke, Carter L. Diggs, Marie-Claude Dubois, Idrissa Traore, Christopher V. Plowe, … Karim Traore. (2013). Extended Safety, Immunogenicity and Efficacy of a Blood-Stage Malaria Vaccine in Malian Children: 24-Month Follow-Up of a Randomized, Double-Blinded Phase 2 Trial. PLoS ONE, 8(11).

Chicago

Modibo Daou, Joe Cohen, Matthew B. Laurens, Jason W. Bennett, William C. Blackwelder, Abdoulaye K. Kone, Amed Ouattara, et al. 2013. “Extended Safety, Immunogenicity and Efficacy of a Blood-Stage Malaria Vaccine in Malian Children: 24-Month Follow-Up of a Randomized, Double-Blinded Phase 2 Trial.” PLoS ONE 8 (11). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e46fe5c167ab3122b212142bd910daf5&authtype=sso&custid=ns315887.